Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors  There are just nine days left in the year, and this year has flown by. We've delivered readers a steady stream of 2026 outlooks over the past few days and weeks, and next up is a year-ahead catalyst list from Goldman S......